Private Capital Management (Florida)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Hold
1,491
0.03% 167
2025
Q4
$341K Hold
1,491
0.03% 150
2025
Q3
$345K Hold
1,491
0.03% 130
2025
Q2
$277K Sell
1,491
-16
-1% -$2.97K 0.03% 140
2025
Q1
$316K Hold
1,507
0.03% 122
2024
Q4
$268K Hold
1,507
0.03% 124
2024
Q3
$298K Hold
1,507
0.03% 114
2024
Q2
$258K Sell
1,507
-99
-6% -$16.4K 0.03% 118
2024
Q1
$293K Sell
1,606
-187
-10% -$32.2K 0.03% 114
2023
Q4
$278K Buy
1,793
+187
+12% +$27.3K 0.03% 125
2023
Q3
$239K Hold
1,606
0.03% 128
2023
Q2
$216K Buy
+1,606
New +$236K 0.03% 133

Other funds holding ABBV

Private Capital Management (Florida)'s ABBV Position: Q1 2026 in Review

Private Capital Management (Florida) held its AbbVie (ABBV) position steady in Q1 2026 at 1,491 shares worth $324K. The position accounts for 0.03% of the portfolio, ranked #167.

Private Capital Management (Florida) first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $345K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Private Capital Management (Florida) held 1,491 shares of AbbVie worth $324K as of Q1 2026.
  • Private Capital Management (Florida) left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.03% of Private Capital Management (Florida)'s portfolio in Q1 2026, its #167 holding.
  • Private Capital Management (Florida) first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
  • Private Capital Management (Florida)'s AbbVie position peaked at $345K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2026, filed 15 May 2026.